Palynziq FDA Approval History
FDA Approved: Yes (First approved May 24, 2018)
Brand name: Palynziq
Generic name: pegvaliase-pqpz
Dosage form: Injection
Company: BioMarin Pharmaceutical Inc.
Treatment for: Phenylketonuria
Palynziq (pegvaliase-pqpz) is a phenylalanine-metabolizing enzyme indicated to reduce blood phenylalanine concentrations in adult patients with phenylketonuria.
Development timeline for Palynziq
| Date | Article |
|---|---|
| May 24, 2018 | Approval FDA Approves Palynziq (pegvaliase-pqpz) for the Treatment of Adults with Phenylketonuria |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
